229 related articles for article (PubMed ID: 22569286)
1. Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.
Panda H; Pelakh L; Chuang TD; Luo X; Bukulmez O; Chegini N
Reprod Sci; 2012 Aug; 19(8):786-96. PubMed ID: 22569286
[TBL] [Abstract][Full Text] [Related]
2. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.
Chuang TD; Panda H; Luo X; Chegini N
Endocr Relat Cancer; 2012 Aug; 19(4):541-56. PubMed ID: 22685266
[TBL] [Abstract][Full Text] [Related]
3. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
4. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.
Asakura T; Yamaguchi N; Ohkawa K; Yoshida K
Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863
[TBL] [Abstract][Full Text] [Related]
6. HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium.
Du H; Sarno J; Taylor HS
Biol Reprod; 2010 Aug; 83(2):205-11. PubMed ID: 20463357
[TBL] [Abstract][Full Text] [Related]
7. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
[TBL] [Abstract][Full Text] [Related]
8. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF
Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
Hurteau GJ; Carlson JA; Spivack SD; Brock GJ
Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1.
Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q
Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
[TBL] [Abstract][Full Text] [Related]
12. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.
Bendoraite A; Knouf EC; Garg KS; Parkin RK; Kroh EM; O'Briant KC; Ventura AP; Godwin AK; Karlan BY; Drescher CW; Urban N; Knudsen BS; Tewari M
Gynecol Oncol; 2010 Jan; 116(1):117-25. PubMed ID: 19854497
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
14. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
[TBL] [Abstract][Full Text] [Related]
15. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor.
Renthal NE; Chen CC; Williams KC; Gerard RD; Prange-Kiel J; Mendelson CR
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20828-33. PubMed ID: 21079000
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
[TBL] [Abstract][Full Text] [Related]
17. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-142-3p suppresses endometriosis by regulating KLF9-mediated autophagy
Ma L; Li Z; Li W; Ai J; Chen X
RNA Biol; 2019 Dec; 16(12):1733-1748. PubMed ID: 31425004
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
